DarioHealth Corp. (DRIO)
Healthcare
- Fundamental
- 2
- Sentiment
- 2
- Technical
- 2
Do Nothing: fundamentalScore 2 and qualitativeScore 2 are below the required floor of 3, and liquidity is far below the strategy minimums.
Company overview
DarioHealth Corp. is a digital therapeutics company offering solutions for metabolic, musculoskeletal, and behavioral health conditions across several regions including the US and EU. Their products include digital health platforms and connected devices for chronic condition management. Founded in 2011, the company is headquartered in New York.
Fundamental
weakDarioHealth shows attractive gross margins but faces high cash burn and declining revenue, making it reliant on external financing.
Small-cap digital therapeutics company with solid gross margins but shrinking revenue and substantial ongoing losses/cash burn. Recent equity financing improves near-term liquidity and SEC filings show no explicit going-concern warning, but the business still relies on external capital and carries high execution/regulatory risk—better treated as a speculative watchlist name than a fundamentals-driven buy.
Sentiment
weakRecent sentiment is bearish, with media coverage focusing on revenue declines and ongoing losses.
Post–2026-08-11 Q2 results coverage (announced) has been net-negative and was followed by estimate-cut commentary (2026-08-17), keeping the near-term narrative skewed bearish. The media sentiment delta is determinately negative (30–90d polarity_score ≈ +0.50 → last ~14d ≈ -0.25); legal/regulatory scans found no active cases/investigations, but a moderate red-flag cap applies because the deterioration lacks an offsetting bullish near-term catalyst.
Technical
weakThe stock shows weak momentum, trading below key moving averages with fading post-earnings bounce.
Price is only marginally above the SMA50 but remains below the SMA20, SMA200, EMA9, EMA21, and the latest daily VWAP; RSI14 is 47.84 and MACD 0.07 is below its 0.09 signal, showing the post-earnings bounce has lost momentum despite ADX 33.65.
You’re looking at 2026-08-19 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Healthcare
Not financial advice. For informational and educational purposes only.